John J. Masterson bought $9,870 of BSBK
director at Bogota Financial Corp.. 1,400 shares at an average of $7.05, traded May 23, 2025, filed May 27, 2025.
Score components
- +15RoleDirector
- 0Trade size$10k at market
- -5Relative to holdingsUnder 1% of holdings (0.8%)
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +12.0%, 3m +31.0%, 6m +20.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-25-018538, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 23, 2025 | POpen-market purchase Common Stock | +1,400 | $7.05 | $9,870 | 179,695 | May 27, 2025 |
Related signals
Other insiders at Bogota Financial Corp. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 20Weak | BSBKbuy Bogota Financial Corp. | John J. Masterson director | $18k 2,200 shares | +1% | |
| 10Weak | BSBKbuy Bogota Financial Corp. | John J. Masterson director | $13k 1,600 shares | +1% | |
| 15Weak | BSBKbuy Bogota Financial Corp. | John J. Masterson director | $9,060 1,200 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.